Journal for ImmunoTherapy of Cancer (Nov 2021)
527 Digital spatial profiling of paired tumor biopsies reveals indoleamine 2,3-dioxygenase (IDO)1 as a potential resistance mechanism for a tumor-targeted 4–1BB agonist in patients with solid tumors
Abstract
No abstracts available.